The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population

After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a single...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical pharmacology 1989-01, Vol.29 (1), p.25-32
Hauptverfasser: Cummings, Doyle M., Amadio Jr, Peter, Taylor Jr, Elmer J., Balaban, Donald J., Rocci Jr, Mario L., Abrams, William B., Feinberg, Jerry, Vlasses, Peter H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 32
container_issue 1
container_start_page 25
container_title Journal of clinical pharmacology
container_volume 29
creator Cummings, Doyle M.
Amadio Jr, Peter
Taylor Jr, Elmer J.
Balaban, Donald J.
Rocci Jr, Mario L.
Abrams, William B.
Feinberg, Jerry
Vlasses, Peter H.
description After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.
doi_str_mv 10.1002/j.1552-4604.1989.tb03233.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78942642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78942642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</originalsourceid><addsrcrecordid>eNqVkF1v0zAUhi0EGt3gJyBZCHGX4K84ya7oqn0wVaOgARI3luMcM3epHeJ0a_89iRr1nitbep_z-vhB6D0lKSWEfVqnNMtYIiQRKS2LMu0rwhnn6e4Fmh2jl2hGSEkTlhPyGp3GuCaESpHRE3TCMkEYEzNU3T8AnvvePexb6Hrw0T0B_g6xDT4C7gNeuuh8aDvXnOMRvrQWTI-DxfM_gJ3HGq86qMPGee37Zo8vGm0e8Sq020b3Lvg36JXVTYS303mGflxd3i9ukuXX6y-L-TIxghc80SKzwAkrJKuEzbjURQVSC6i0FAXlYGuTCSm0rI0GkktqTFnyoioNl3UB_Ax9PPS2Xfi7hdirjYsGmkZ7CNuo8qIUTAo2gOcH0HQhxg6sGn630d1eUaJGwWqtRotqtKhGwWoSrHbD8LvplW21gfo4Ohkd8g9TrqPRje20Ny4eMSmLrGTlgH0-YM-ugf1_LKBuF6ub8TpUJIcKF3vYHSt096hkzvNM_bq7VpyJbz9_X1C14v8AlpWnyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78942642</pqid></control><display><type>article</type><title>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cummings, Doyle M. ; Amadio Jr, Peter ; Taylor Jr, Elmer J. ; Balaban, Donald J. ; Rocci Jr, Mario L. ; Abrams, William B. ; Feinberg, Jerry ; Vlasses, Peter H.</creator><creatorcontrib>Cummings, Doyle M. ; Amadio Jr, Peter ; Taylor Jr, Elmer J. ; Balaban, Donald J. ; Rocci Jr, Mario L. ; Abrams, William B. ; Feinberg, Jerry ; Vlasses, Peter H.</creatorcontrib><description>After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.</description><identifier>ISSN: 0091-2700</identifier><identifier>EISSN: 1552-4604</identifier><identifier>DOI: 10.1002/j.1552-4604.1989.tb03233.x</identifier><identifier>PMID: 2540224</identifier><identifier>CODEN: JCPCBR</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; African Continental Ancestry Group ; Aged ; Aged, 80 and over ; Aging - physiology ; Aldosterone - blood ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive agents ; Biological and medical sciences ; Cardiovascular system ; Enalapril - adverse effects ; Enalapril - analogs &amp; derivatives ; Enalapril - therapeutic use ; Female ; Humans ; Hydrochlorothiazide - therapeutic use ; Hypertension - drug therapy ; Lisinopril ; Male ; Medical sciences ; Middle Aged ; Peptidyl-Dipeptidase A - blood ; Pharmacology. Drug treatments ; Potassium - blood ; Renin - blood</subject><ispartof>Journal of clinical pharmacology, 1989-01, Vol.29 (1), p.25-32</ispartof><rights>1989 American College of Clinical Pharmacology</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</citedby><cites>FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fj.1552-4604.1989.tb03233.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fj.1552-4604.1989.tb03233.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6685929$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2540224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cummings, Doyle M.</creatorcontrib><creatorcontrib>Amadio Jr, Peter</creatorcontrib><creatorcontrib>Taylor Jr, Elmer J.</creatorcontrib><creatorcontrib>Balaban, Donald J.</creatorcontrib><creatorcontrib>Rocci Jr, Mario L.</creatorcontrib><creatorcontrib>Abrams, William B.</creatorcontrib><creatorcontrib>Feinberg, Jerry</creatorcontrib><creatorcontrib>Vlasses, Peter H.</creatorcontrib><title>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</title><title>Journal of clinical pharmacology</title><addtitle>J Clin Pharmacol</addtitle><description>After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.</description><subject>Adult</subject><subject>African Continental Ancestry Group</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging - physiology</subject><subject>Aldosterone - blood</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Enalapril - adverse effects</subject><subject>Enalapril - analogs &amp; derivatives</subject><subject>Enalapril - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Hydrochlorothiazide - therapeutic use</subject><subject>Hypertension - drug therapy</subject><subject>Lisinopril</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peptidyl-Dipeptidase A - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium - blood</subject><subject>Renin - blood</subject><issn>0091-2700</issn><issn>1552-4604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF1v0zAUhi0EGt3gJyBZCHGX4K84ya7oqn0wVaOgARI3luMcM3epHeJ0a_89iRr1nitbep_z-vhB6D0lKSWEfVqnNMtYIiQRKS2LMu0rwhnn6e4Fmh2jl2hGSEkTlhPyGp3GuCaESpHRE3TCMkEYEzNU3T8AnvvePexb6Hrw0T0B_g6xDT4C7gNeuuh8aDvXnOMRvrQWTI-DxfM_gJ3HGq86qMPGee37Zo8vGm0e8Sq020b3Lvg36JXVTYS303mGflxd3i9ukuXX6y-L-TIxghc80SKzwAkrJKuEzbjURQVSC6i0FAXlYGuTCSm0rI0GkktqTFnyoioNl3UB_Ax9PPS2Xfi7hdirjYsGmkZ7CNuo8qIUTAo2gOcH0HQhxg6sGn630d1eUaJGwWqtRotqtKhGwWoSrHbD8LvplW21gfo4Ohkd8g9TrqPRje20Ny4eMSmLrGTlgH0-YM-ugf1_LKBuF6ub8TpUJIcKF3vYHSt096hkzvNM_bq7VpyJbz9_X1C14v8AlpWnyw</recordid><startdate>198901</startdate><enddate>198901</enddate><creator>Cummings, Doyle M.</creator><creator>Amadio Jr, Peter</creator><creator>Taylor Jr, Elmer J.</creator><creator>Balaban, Donald J.</creator><creator>Rocci Jr, Mario L.</creator><creator>Abrams, William B.</creator><creator>Feinberg, Jerry</creator><creator>Vlasses, Peter H.</creator><general>Blackwell Publishing Ltd</general><general>Sage Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198901</creationdate><title>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</title><author>Cummings, Doyle M. ; Amadio Jr, Peter ; Taylor Jr, Elmer J. ; Balaban, Donald J. ; Rocci Jr, Mario L. ; Abrams, William B. ; Feinberg, Jerry ; Vlasses, Peter H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>African Continental Ancestry Group</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging - physiology</topic><topic>Aldosterone - blood</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Enalapril - adverse effects</topic><topic>Enalapril - analogs &amp; derivatives</topic><topic>Enalapril - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Hydrochlorothiazide - therapeutic use</topic><topic>Hypertension - drug therapy</topic><topic>Lisinopril</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peptidyl-Dipeptidase A - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium - blood</topic><topic>Renin - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cummings, Doyle M.</creatorcontrib><creatorcontrib>Amadio Jr, Peter</creatorcontrib><creatorcontrib>Taylor Jr, Elmer J.</creatorcontrib><creatorcontrib>Balaban, Donald J.</creatorcontrib><creatorcontrib>Rocci Jr, Mario L.</creatorcontrib><creatorcontrib>Abrams, William B.</creatorcontrib><creatorcontrib>Feinberg, Jerry</creatorcontrib><creatorcontrib>Vlasses, Peter H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cummings, Doyle M.</au><au>Amadio Jr, Peter</au><au>Taylor Jr, Elmer J.</au><au>Balaban, Donald J.</au><au>Rocci Jr, Mario L.</au><au>Abrams, William B.</au><au>Feinberg, Jerry</au><au>Vlasses, Peter H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</atitle><jtitle>Journal of clinical pharmacology</jtitle><addtitle>J Clin Pharmacol</addtitle><date>1989-01</date><risdate>1989</risdate><volume>29</volume><issue>1</issue><spage>25</spage><epage>32</epage><pages>25-32</pages><issn>0091-2700</issn><eissn>1552-4604</eissn><coden>JCPCBR</coden><abstract>After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2540224</pmid><doi>10.1002/j.1552-4604.1989.tb03233.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-2700
ispartof Journal of clinical pharmacology, 1989-01, Vol.29 (1), p.25-32
issn 0091-2700
1552-4604
language eng
recordid cdi_proquest_miscellaneous_78942642
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
African Continental Ancestry Group
Aged
Aged, 80 and over
Aging - physiology
Aldosterone - blood
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive agents
Biological and medical sciences
Cardiovascular system
Enalapril - adverse effects
Enalapril - analogs & derivatives
Enalapril - therapeutic use
Female
Humans
Hydrochlorothiazide - therapeutic use
Hypertension - drug therapy
Lisinopril
Male
Medical sciences
Middle Aged
Peptidyl-Dipeptidase A - blood
Pharmacology. Drug treatments
Potassium - blood
Renin - blood
title The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A45%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Antihypertensive%20Response%20to%20Lisinopril:%20The%20Effect%20of%20Age%20in%20a%20Predominantly%20Black%20Population&rft.jtitle=Journal%20of%20clinical%20pharmacology&rft.au=Cummings,%20Doyle%20M.&rft.date=1989-01&rft.volume=29&rft.issue=1&rft.spage=25&rft.epage=32&rft.pages=25-32&rft.issn=0091-2700&rft.eissn=1552-4604&rft.coden=JCPCBR&rft_id=info:doi/10.1002/j.1552-4604.1989.tb03233.x&rft_dat=%3Cproquest_cross%3E78942642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78942642&rft_id=info:pmid/2540224&rfr_iscdi=true